154312-86-4 Usage
Description
4-(Chloromethyl)-1-methylpyrazole Hydrochloride is an organic compound that serves as a useful building block for various synthetic routes. It is characterized by its chloromethyl group and pyrazole ring, which contribute to its reactivity and potential applications in chemical synthesis.
Uses
Used in Chemical Synthesis:
4-(Chloromethyl)-1-methylpyrazole Hydrochloride is used as a building block for various synthetic routes in the chemical industry. Its unique structure allows for the creation of a wide range of compounds, making it a valuable asset in the development of new materials and pharmaceuticals.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 4-(Chloromethyl)-1-methylpyrazole Hydrochloride is used as an intermediate in the synthesis of various drugs. Its versatility and reactivity enable the development of novel therapeutic agents with potential applications in treating various medical conditions.
Used in Research and Development:
4-(Chloromethyl)-1-methylpyrazole Hydrochloride is also utilized in research and development settings, where it can be employed to explore new chemical reactions and investigate the properties of related compounds. This contributes to the advancement of scientific knowledge and the discovery of innovative applications in various fields.
Check Digit Verification of cas no
The CAS Registry Mumber 154312-86-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,4,3,1 and 2 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 154312-86:
(8*1)+(7*5)+(6*4)+(5*3)+(4*1)+(3*2)+(2*8)+(1*6)=114
114 % 10 = 4
So 154312-86-4 is a valid CAS Registry Number.
154312-86-4Relevant articles and documents
FLUOROINDOLE DERIVATIVES AS MUSCARINIC M1 RECEPTOR POSITIVE ALLOSTERIC MODULATORS
-
Page/Page column 22; 23, (2017/03/28)
The present invention relates to compound of formula (I), or stereoisomers and pharmaceutically acceptable salts as muscarinic M1 receptor positive allosteric modulators. This invention also relates to methods of making such compounds and pharmaceutical compositions comprising such compounds. The compounds of this invention are useful in the treatment of various disorders that are related to muscarinic M1 receptor.(Formula I) (I)
